|Last Price||148.90||Max Price||149.70|
|Min Price||81.26||1 Year return||41.34|
Merck KGaA primarily operates in the pharmaceutical sector. The global pharmaceutical companies gained around 75 percent over the last 10 years. Measured since 2011 the sector is 147 percent higher and over the past 12 months (December 2015-December 2016) there is a minus of 75 percent.
Over the last 12 months, that were profitable period for the investors in Merck KGaA, the stock gained around 12 percent. Merck KGaA' stock rose the past 5 years at around 164 percent. Merck KGaA's revenues between 2011 and 2015 were quite similar and moved between 11,17 billion euros and 12,84 billion euros. During 2011 and 2015 Merck KGaA's net results were quiet stable and fluctuated between 629 million euros and 1,12 billion euros.
Merck KGaA paid out dividends in the past 5 years. Merck KGaA's dividend return over the period 2011 - 2015 was around 4,6 percent per year.
Merck KGaA had about 39,64 thousand employees at the end of 2015.
At the end of 2015 the German company had a balance sheet of around 38,01 billion euros. The total debt was around 25,22 billion euros. This is 66,36 percent of the total balance sheet. Last year the pharmaceutical company's price/earnings-ratio (PE) was around 25. So the investors valued the stock at 25 times 2015' earnings per share. We could say that based on it's price/earnings-ratio and dividend yield the German stock can be seen as a value stock.
At the end of 2015 the German company's market capitalization equaled around 37,51 billion euros. At the end of 2015 around 434,78 million stocks were listed.